These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 18781151)
1. GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics. Kristiansen G; Fritzsche FR; Wassermann K; Jäger C; Tölls A; Lein M; Stephan C; Jung K; Pilarsky C; Dietel M; Moch H Br J Cancer; 2008 Sep; 99(6):939-48. PubMed ID: 18781151 [TBL] [Abstract][Full Text] [Related]
2. Comparison of annexin II, p63 and alpha-methylacyl-CoA racemase immunoreactivity in prostatic tissue: a tissue microarray study. Stewart J; Fleshner N; Cole H; Sweet J J Clin Pathol; 2007 Jul; 60(7):773-80. PubMed ID: 16916997 [TBL] [Abstract][Full Text] [Related]
3. Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer. Luo J; Zha S; Gage WR; Dunn TA; Hicks JL; Bennett CJ; Ewing CM; Platz EA; Ferdinandusse S; Wanders RJ; Trent JM; Isaacs WB; De Marzo AM Cancer Res; 2002 Apr; 62(8):2220-6. PubMed ID: 11956072 [TBL] [Abstract][Full Text] [Related]
4. Kinetic fluorescence reverse transcriptase-polymerase chain reaction for alpha-methylacyl CoA racemase distinguishes prostate cancer from benign lesions. Schostak M; Miller K; Krause H; Schrader M; Kempkensteffen C; Kollermann J Cancer Detect Prev; 2006; 30(5):449-54. PubMed ID: 17067752 [TBL] [Abstract][Full Text] [Related]
5. Expression and diagnostic utility of alpha-methylacyl-CoA-racemase (P504S) in foamy gland and pseudohyperplastic prostate cancer. Zhou M; Jiang Z; Epstein JI Am J Surg Pathol; 2003 Jun; 27(6):772-8. PubMed ID: 12766580 [TBL] [Abstract][Full Text] [Related]
6. alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. Rubin MA; Zhou M; Dhanasekaran SM; Varambally S; Barrette TR; Sanda MG; Pienta KJ; Ghosh D; Chinnaiyan AM JAMA; 2002 Apr; 287(13):1662-70. PubMed ID: 11926890 [TBL] [Abstract][Full Text] [Related]
7. Global expression of AMACR transcripts predicts risk for prostate cancer - a systematic comparison of AMACR protein and mRNA expression in cancerous and noncancerous prostate. Alinezhad S; Väänänen RM; Ochoa NT; Vertosick EA; Bjartell A; Boström PJ; Taimen P; Pettersson K BMC Urol; 2016 Feb; 16():10. PubMed ID: 26928323 [TBL] [Abstract][Full Text] [Related]
8. Alpha-methylacyl-CoA racemase: a variably sensitive immunohistochemical marker for the diagnosis of small prostate cancer foci on needle biopsy. Magi-Galluzzi C; Luo J; Isaacs WB; Hicks JL; de Marzo AM; Epstein JI Am J Surg Pathol; 2003 Aug; 27(8):1128-33. PubMed ID: 12883245 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate. Herawi M; Epstein JI Am J Surg Pathol; 2007 Jun; 31(6):889-94. PubMed ID: 17527076 [TBL] [Abstract][Full Text] [Related]
11. Reliability of the 34βE12, keratin 5/6, p63, bcl-2, and AMACR in the diagnosis of prostate carcinoma. Boran C; Kandirali E; Yilmaz F; Serin E; Akyol M Urol Oncol; 2011; 29(6):614-23. PubMed ID: 20189848 [TBL] [Abstract][Full Text] [Related]
12. 34BetaE12 and Alfa-Methylacyl Coenzyme A Racemase (AMACR) Antibodies Better Than p63 Antibody Distinguish Normal and Neoplastic Glands in Prostatic Tissue With Thermal Artifacts. Pierconti F; Rossi ED; Martini M; Sacco E; Bassi PF; Larocca LM Appl Immunohistochem Mol Morphol; 2019 Apr; 27(4):306-310. PubMed ID: 29346181 [TBL] [Abstract][Full Text] [Related]
13. MAGI-2 Is a Sensitive and Specific Marker of Prostatic Adenocarcinoma: A Comparison With AMACR. Goldstein J; Goyal R; Roland JT; Gellert LL; Clark PE; Hameed O; Giannico GA Am J Clin Pathol; 2016 Sep; 146(3):294-302. PubMed ID: 27543977 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of alpha-methylacyl-CoA racemase, metallothionein and prostate specific antigen as prostate cancer prognostic markers. Gumulec J; Masarik M; Krizkova S; Hlavna M; Babula P; Hrabec R; Rovny A; Masarikova M; Sochor J; Adam V; Eckschlager T; Kizek R Neoplasma; 2012; 59(2):191-201. PubMed ID: 22248277 [TBL] [Abstract][Full Text] [Related]
16. How often does alpha-methylacyl-CoA-racemase contribute to resolving an atypical diagnosis on prostate needle biopsy beyond that provided by basal cell markers? Zhou M; Aydin H; Kanane H; Epstein JI Am J Surg Pathol; 2004 Feb; 28(2):239-43. PubMed ID: 15043314 [TBL] [Abstract][Full Text] [Related]
17. Alpha-methylacyl-CoA racemase: a multi-institutional study of a new prostate cancer marker. Jiang Z; Wu CL; Woda BA; Iczkowski KA; Chu PG; Tretiakova MS; Young RH; Weiss LM; Blute RD; Brendler CB; Krausz T; Xu JC; Rock KL; Amin MB; Yang XJ Histopathology; 2004 Sep; 45(3):218-25. PubMed ID: 15330799 [TBL] [Abstract][Full Text] [Related]
18. The value of triple antibody (34βE12 + p63 + AMACR) cocktail stain in radical prostatectomy specimens with crushed surgical margins. Daoud NA; Li G; Evans AJ; van der Kwast TH J Clin Pathol; 2012 May; 65(5):437-40. PubMed ID: 22294716 [TBL] [Abstract][Full Text] [Related]
19. Discovery and clinical application of a novel prostate cancer marker: alpha-methylacyl CoA racemase (P504S). Jiang Z; Woda BA; Wu CL; Yang XJ Am J Clin Pathol; 2004 Aug; 122(2):275-89. PubMed ID: 15323145 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic utility of p63 and α-methyl acyl Co A racemase in resolving suspicious foci in prostatic needle biopsy and transurethral resection of prostate specimens. Singh V; Manu V; Malik A; Dutta V; Mani NS; Patrikar S J Cancer Res Ther; 2014; 10(3):686-92. PubMed ID: 25313761 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]